Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
CRYSTAL FORM OF MACROCYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/045360
Kind Code:
A1
Abstract:
The present invention relates to the technical field of drug synthesis. Disclosed are a crystal form of a macrocyclic compound, and a preparation method therefor and the use thereof. The macrocyclic compound is (6R, 16R)-9-fluoro-16-methyl-13-oxa-2,17,21,25-tetraazapentane [16.6.2.02,6.07,12.022,26]dihexadecane-1(25),7,9,11,18(26),19,21,23-octane-19-carbonitrile. The X-ray diffraction pattern of the crystal form has characteristic peaks at 2θ values of 9.49 ± 0.2, 10.60 ± 0.2, 11.54 ± 0.2, 14.10 ± 0.2, 17.09 ± 0.2, 19.15 ± 0.2, 20.30 ± 0.2, 22.85 ± 0.2, 23.89 ± 0.2, and 27.74 ± 0.2. The crystal form is hygroscopicity-free, and has a good stability and pharmacokinetic properties.

Inventors:
GUO RUIZHI (CN)
WANG JIANSONG (CN)
LUO ZHIBO (CN)
HUANG HAIWEN (CN)
QIN FEI (CN)
WANG WEI (CN)
YE HAIHONG (CN)
QIAN RIBIN (CN)
Application Number:
PCT/CN2022/093322
Publication Date:
March 30, 2023
Filing Date:
May 17, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
HITGEN INC (CN)
International Classes:
C07D471/04; A61P9/10; A61P11/06; A61P13/08; A61P13/10; A61P13/12; A61P17/10; A61P19/02; A61P19/08; A61P25/06; A61P25/16; A61P25/28; A61P35/00; A61P37/06; A61P37/08
Domestic Patent References:
WO2010085597A12010-07-29
Foreign References:
CN113754657A2021-12-07
CN110386945A2019-10-29
CN113121568A2021-07-16
CN112174982A2021-01-05
CN110386945A2019-10-29
Other References:
"China Pharmacopoeia", 2020, pages: 9103
Attorney, Agent or Firm:
GAOYUNG INTELLECTUAL PROPERTY AGENCY (GENERAL PARTNERSHIP) (CN)
Download PDF: